<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02250469</url>
  </required_header>
  <id_info>
    <org_study_id>12-SMI-2014</org_study_id>
    <nct_id>NCT02250469</nct_id>
  </id_info>
  <brief_title>A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthesia Between 2 Spinal Cord Stimulation Systems</brief_title>
  <acronym>CHARACTER SCS</acronym>
  <official_title>A Randomised Pilot Study to Assess differenCes in tHe Subjects' Experience of stimulAtion-Induced paRaesthesiA Between Two Different Spinal Cord sTimulation dEvices: the AxiumÂ® DoRsal Root Ganglion Stimulation System Versus the Prime Advanced Dorsal Column Stimulation System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      12-SMI-2014 is a post-market, randomised, pilot study to identify and rate differences in
      patient experiences with two different types of Spinal Cord Stimulator devices which are
      routinely used to treat chronic pain.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Specificity of Stimulation Induced Paresthesia</measure>
    <time_frame>3 Months post implantation</time_frame>
    <description>A comparative analysis will be made between groups to determine the percentage of a patients painful and non-painful anatomy that is covered by stimulation induced paresthesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stability of Stimulation Induced Paresthesia</measure>
    <time_frame>3 Months post implantation</time_frame>
    <description>A comparative analysis will be made between groups to determine any changes in the intensity of stimulation induced paresthesia in response to changes in body position</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Interactions with System</measure>
    <time_frame>3 Months post implantation</time_frame>
    <description>A comparative analysis will be made between groups to determine the number of device interactions patients need to have on average, daily</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Axium SCS System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation with the Axium Neurostimulator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medtronic SCS System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation with the Medtronic Prime Advanced Dorsal Column Stimulation System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Treatment with the Axium SCS system</intervention_name>
    <arm_group_label>Axium SCS System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Treatment with the Medtronic SCS System</intervention_name>
    <arm_group_label>Medtronic SCS System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is appropriate for SCS implantation according to standard criteria

          2. Subject is &gt;18 to &lt;75 years old

          3. Subject is able and willing to comply with the follow-up schedule and protocol

          4. Subject has chronic (&gt; 6 months) uni/bi-lateral neuropathic pain in the lower limb(s)
             (below the knee) with predominant foot pain

          5. Minimum baseline pain rating of 50 mm on the VAS in the primary region of pain

          6. Subject is able to provide written informed consent

        Exclusion Criteria:

          1. Subject has no other exclusion criteria for SCS implantation according to standard
             criteria

          2. Subject has had corticosteroid therapy at an intended site of stimulation within the
             past 30 days

          3. Subject has had radiofrequency treatment of an intended target DRG within the past 3
             months

          4. Subject has participated in another clinical study within 30 days

          5. Subject has been previously treated with and failed to respond to an implantable
             neuromodulation therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M W Hollmann, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>AIDS Malignancy Consortium</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Academisch Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2014</study_first_submitted>
  <study_first_submitted_qc>September 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2014</study_first_posted>
  <last_update_submitted>January 16, 2017</last_update_submitted>
  <last_update_submitted_qc>January 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Paresthesia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

